 Ciprofloxacin targets prokaryotes in excess of a thousandfold more than it targets eukaryotic topo IIs.Despite this, Ciprofloxacin is a potent dose-dependent type II poison, which is why it causes mass destruction of tissue cells.This poor safety profile is one reason the FDA has advised fluoroquinolones only be used as a treatment of last resort.